Risk-based Monitoring Software Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

SKU ID : FPG- 18330189

Publishing Date : 20-Mar-2021

No. of pages : 177

PRICE
5000
10000

  • Risk-based Monitoring Software Market: Market Segments: By Component (Software and Services); By Delivery Mode (Web-based, Licensed Enterprise and Cloud-based); By End-User (Pharmaceutical & Biopharmaceutical Companies, CROs, Medical Device Companies and Others); and Region – Global Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2030
    Product Overview
    Risk-based monitoring software provides clinical teams with a single platform that transforms numerous study data streams into actionable analytics. The result is a more focused and data driven monitoring effort that enables sponsor oversight and improves the quality and compliance of a clinical trial or program.
    Market Highlights
    Risk-based Monitoring Software Market is expected to project a notable CAGR of 13.6% in 2030.
    Risk-based Monitoring Software Market to surpass USD 593 Million by 2030 from USD 268 Million in 2019 at a CAGR of 13.6% throughout the forecast period, i.e., 2020-30. The main factors driving the risk-based monitoring software market are increasing the reliability and expense of risk-based monitoring solutions and increasing governments' investment in supporting clinical trials due to increasing demand.
    Risk-based Monitoring Software Market: Segments
    Software segment to grow with the highest CAGR during 2020-30
    Risk-based Monitoring Software Market is segmented by component into software and services. The greater market share in 2019 was accounted by software segment of the global risk-based monitoring software. The R&D expenditure in the life sciences and clinical research industries, the rising number of clinical trials, and the increasing customer base can be attributed to the large share of this market.
    Risk-based Monitoring Software Market: Market Dynamics
    Drivers
    Growing investments by governments to support clinical trials
    Main factors driving the risk-based monitoring software market are increasing the reliability and expense of risk-based monitoring solutions and increasing governments' investment in supporting clinical trials due to increasing demand. Major market players are focused on the launch of updated versions of risk-based monitoring software, which is expected to fuel the demand for risk-based monitoring software in pharmaceutical and biopharmaceutical companies, medical device companies, and CROs.
    Restrain
    High cost related with Risk-based Monitoring Software
    There is a considerably high cost of implementation of risk-based monitoring solutions and interoperability solutions for various medical devices. It is a major challenge for healthcare organizations to resolve such financial constraints, especially in emerging economies where budgetary approvals for IT solutions over medical equipment are usually difficult to obtain.
    Risk-based Monitoring Software Market: Key Players
    • Medidata Solutions
    • Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence and SWOT Analysis.
    • Parexel
    • Bioclinica
    • Bio-Optronics
    • IBM Corporation
    • DATATRAK
    • Veeva Systems
    • DSG
    • MasterControl
    Risk-based Monitoring Software Market: Regions
    Risk-based Monitoring Software Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC and MENA.
    Risk-based Monitoring Software Market in North America held the largest market share of XX.X% in the year 2019 and is expected to continue its stronghold for a few more years. In the forecast era, the Asia Pacific market is projected to expand at the highest CAGR. This growth can be attributed to increased government funding to support clinical trials, the presence of less strict regulatory standards relative to developed countries, a broad patient population, low operational costs for clinical trials, the lack of volunteer trials in Europe and North America, and the region's growing number of pharmaceutical companies and CROs.
    Risk-based Monitoring Software Market report also contains analysis on:
    Risk-based Monitoring Software Market Segments:
    By Component:
    • Software
    • Services
    By Delivery Mode:
    • Web-based
    • Licensed Enterprise
    • Cloud-based
    By End-User:
    • Pharmaceutical & Biopharmaceutical Companies
    • CROs
    • Medical Device Companies
    • Other

    • Risk-based Monitoring Software Market Dynamics
    • Risk-based Monitoring Software Market Size
    • Supply & Demand
    • Current Trends/Issues/Challenges
    • Competition & Companies Involved in the Market
    • Value Chain of the Market
    • Market Drivers and Restraints


    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports